← feed

Is NCT02475447 results overdue?

Yes — results are overdue. Primary completion was 2017-06; the FDAAA-801 reporting deadline (2018-06-30) passed 2913 days ago and no results are posted on ClinicalTrials.gov.

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

NCT IDNCT02475447 ↗
SponsorTioga Pharmaceuticals (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2017-06 (ACTUAL)
Reporting deadline2018-06-30 (completion + 365d)
Days overdue2913
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 965805521f1ede06… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02475447. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →